Rabi Hanna: Gene Therapy Is Transforming Sickle Cell Disease
Rabi Hanna, Chairman, Department of Pediatric hematology-oncology and BMT at Cleveland Clinic Children’s at Cleveland Clinic, shared a post on LinkedIn:
“Today, on World Sickle Cell Day, I had the distinct honor of speaking at the Dutch Sickle Cell event in Amsterdam.
A special thank you to Erfan Nur for the invitation and the opportunity to join this critical conversation. It is a privilege to present an update on the rapidly evolving landscape of sickle cell gene therapy
While the scientific advancements we are seeing are groundbreaking, our work is far from finished.
The true measure of our success will be ensuring that these potentially curative treatments are accessible to everyone who needs them, regardless of geography or socioeconomic status.
Thank you to the Dutch SCD community for hosting such an inspiring event. Let’s continue pushing the boundaries of science while fighting for equitable care.”

Stay updated with Hemostasis Today.
-
Nov 17, 2026, 14:54Cindy Neunert: Beyond Platelet Counts – Addressing Fatigue and Whole-Person Care in ITP
-
Nov 17, 2026, 14:44Strengthening Haemophilia Diagnosis Through Hands-On Laboratory Training – IAHAD
-
Nov 17, 2026, 14:40Platelet Membrane Protrusions Beyond Their Role in Hemostasis – JTH
-
Nov 17, 2026, 14:10Wolfgang Miesbach: Aspirin vs Anticoagulants – Who Needs More Than Aspirin?
-
Nov 17, 2026, 14:08Chaza Alaji: Soluble Transferrin Receptor – A Key to Uncovering Hidden Iron Deficiency
-
Nov 17, 2026, 14:03Shadi Tabibian: Fibrinogen – From Molecular Structure to Clinical Decision Making
-
Nov 17, 2026, 13:54Gabrielle Sarlon: Breaking the Silence on Menstrual Bleeding During Anticoagulant Therapy
-
Nov 17, 2026, 13:47Ksenia Guznova Kats: Advanced Venous Stenting in May–Thurner Syndrome
-
Nov 17, 2026, 13:37Abdlemewla Ibrahim: Prasugrel vs Ticagrelor in ACS Patients Undergoing PCI